Translational Cancer Research · 2021 · 22 citations · 23 references
MedicineMolecular BiologyOncologyCancer GeneticsMolecular OncologyOncogenesCancer GenomicsCancer Molecular PathologyCancer TranscriptomicsImmuno-oncology BiomarkersMolecular Classification Of TumorsMolecular Tumor ProfilingCancer Genomics DatabasesComparative Cancer Gene Expression ProfilesKeratin 17Oncogenic TransformationProtein Expression BiomarkersProtein Expression LevelsTumor ImmunogenomicsTumor Stage Prognosis
Background: Although new evidence from cells or animals suggests a relationship between Keratin 17 (KRT17) and cancer, no pan-cancer analysis is currently available. Methods: The expression level of KRT17 in generalized carcinoma was detected by the Tumor Immune Estimation Resource, version 2 (TIMER2) database, and then verified the protein expression of KRT17 in different cancer species in UALCAN database, and analyzed the relationship between the expression level of KRT17 and the clinical stage and survival of different cancers. We further explored the genetic variation of KRT17 in different tumor types included in The Cancer Genome Atlas (TCGA) and the specific mutations in each domain. The changes of KRT17 protein phosphorylation levels and protein expression levels at different phosphorylation sites in different tumors were explored. TIMER2 database was used to explore the potential relationship between the infiltration level of different immune cells and KRT17 gene expression in different TCGA cancer types. Finally, the protein binding to KRT17 and genes related to KRT17 expression were explored by STRING database and TCGA database. Results: KRT17 is overexpressed in most malignancies, and we observed a distinct relationship between KRT17 expression and tumor patient prognosis. Enhanced phosphorylation levels of S13, S24, S32, and S39 were observed in several tumors, such as lung adenocarcinoma (LUAD), colon and ovarian cancers, and uterine corpus endometrial carcinoma (UCEC). Intermediate filament cytoskeleton and keratinization may be simultaneously acting with KRT17 on tumor pathogenesis. Conclusions: Our pan-cancer analysis provides relatively complete information on the oncogenic functions of KRT17 in various cancers.
23
Ethan Cerami, Jianjiong Gao, Uğur Doğrusöz et al. · Cancer Discovery · 2012 · 18.4K citations · Full text
Medicine, Bioinformatics, Oncology +15
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao, Bülent Arman Aksoy, Uğur Doğrusöz et al. · Science Signaling · 2013 · 15.9K citations · Full text
Medicine, Bioinformatics, Oncology +17
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang, Boxi Kang, Chenwei Li et al. · Nucleic Acids Research · 2019 · 5.4K citations · Full text
jvenn: an interactive Venn diagram viewer
Philippe Bardou, Jérôme Mariette, Fréderic Escudié et al. · BMC Bioinformatics · 2014 · 2.5K citations · Full text